NCT02003508

Brief Summary

This study will examine how common HPV infection is in teenage males in Australia before and after the introduction of universal school based vaccination of males in Australia.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
345

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jan 2014

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 2, 2013

Completed
4 days until next milestone

First Posted

Study publicly available on registry

December 6, 2013

Completed
26 days until next milestone

Study Start

First participant enrolled

January 1, 2014

Completed
4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 29, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 29, 2017

Completed
2.2 years until next milestone

Results Posted

Study results publicly available

March 6, 2020

Completed
Last Updated

March 6, 2020

Status Verified

March 1, 2020

Enrollment Period

4 years

First QC Date

December 2, 2013

Results QC Date

August 11, 2019

Last Update Submit

March 4, 2020

Conditions

Keywords

PrevalenceHPVHuman papillomavirusVaccination

Outcome Measures

Primary Outcomes (1)

  • Prevalence of Penile HPV Genotypes

    Prevalence of penile HPV genotypes among heterosexually active young men. Percentage of participants with specific genotypes on penile samples, as detected by Linear Array. Participants provided a single penile sample.

    Single study visit (one time point per participant)

Study Arms (2)

Pre-school based vaccination program (not vaccine eligible)

Young (17-19 years) men who were not eligible for school based vaccination due to their age at the time of the programs roll out.

Post-school based vaccination program (vaccine eligible)

Young men (17-19 years) who were eligible for school based vaccination due to their age at the time of the programs roll out.

Eligibility Criteria

Age17 Years - 19 Years
Sexmale
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Males aged 17-19 recruited from sexual health clinics and community sources

You may qualify if:

  • Male
  • Aged 17 to 19
  • Able to complete study requirements
  • Residing in Australia from 12 years of age

You may not qualify if:

  • Males reporting sex with males in the past 12 months

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Melbourne Sexual Health Centre

Melbourne, Victoria, 3053, Australia

Location

Biospecimen

Retention: SAMPLES WITH DNA

Penile sampling for HPV DNA

Results Point of Contact

Title
A/Prof Marcus Chen
Organization
Melbourne Sexual Health Centre

Study Officials

  • Marcus Y Chen, PhD

    Melbourne Sexual Health Centre Alfred Health and Central Clinical School Monash University

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
observational
Observational Model
ECOLOGIC OR COMMUNITY
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Adjunct Associate Professor Central Clinical School and Medical Services Manager Melbourne Sexual Health Centre

Study Record Dates

First Submitted

December 2, 2013

First Posted

December 6, 2013

Study Start

January 1, 2014

Primary Completion

December 29, 2017

Study Completion

December 29, 2017

Last Updated

March 6, 2020

Results First Posted

March 6, 2020

Record last verified: 2020-03

Locations